Joana Maia - Concepedia

Author

Joana Maia

Also Known As

Cláudio Espírito Santo, J. Maia, Joana Maia, Juliana Nunes da Silva Meirelles Doria Maia, Lars Gullbrekken, Maia, Joana Fernandes

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Universidade do Porto Bial (Portugal)National Laboratory for Civil Engineering University of Bonn University of Lisbon

About

Joana Maia is an author at Universidade do Porto specializing in medicine, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	539
2	Engineering	7	7	208
3	Social Sciences	3	3	89
4	Biochemistry	1	1	31
5	Chemical Engineering	1	1	29

Joana Maia

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, parallel‐group phase III study Christian E. Elger, Péter Halász, Joana Maia, Epilepsia	2009	247
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy Elinor Ben‐Menachem, Alberto Alain Gabbai, A. Hufnagel, Epilepsy Research Adjunctive TherapyPsychiatryPartial EpilepsyPsychotropic MedicationEslicarbazepine Acetate	2010	179
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures António Gil‐Nagel, J. Lopes-Lima, Luís Almeida, Acta Neurologica Scandinavica	2009	159
Eslicarbazepine Acetate: A Double‐blind, Add‐on, Placebo‐controlled Exploratory Trial in Adult Patients with Partial‐onset Seizures Christian E. Elger, Meir Bialer, Joyce A. Cramer, Epilepsia	2007	130
Single‐Dose and Steady‐State Pharmacokinetics of Eslicarbazepine Acetate (BIA 2–093) in Healthy Elderly and Young Subjects Luís Almeida, Amílcar Falcão, Joana Maia, The Journal of Clinical Pharmacology Therapeutic Drug MonitoringGeriatricsSteady‐state PharmacokineticsPharmacoepidemiologyPharmacology	2005	101
Long‐term efficacy and safety of eslicarbazepine acetate: Results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy Péter Halász, Joyce A. Cramer, Danilo Hodoba, Epilepsia	2010	96
Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment Luís Almeida, Johané Potgieter, Joana Maia, European Journal of Clinical Pharmacology HepatologyLiver PhysiologyPharmacologyEslicarbazepine AcetateHepatotoxicity	2007	96
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate Joana Maia, Luís Almeida, Amílcar Falcão, International Journal of Clinical Pharmacology and Therapeutics	2008	81
Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2‐093), a new voltage‐gated sodium channel blocker Amílcar Falcão, Joana Maia, Luís Almeida, Biopharmaceutics & Drug Disposition	2007	53
Effect of Food on the Pharmacokinetic Profile of Eslicarbazepine Acetate (BIA 2-093) Joana Maia, Manuel Vaz‐da‐Silva, Luís Almeida, Drugs in R&D NutritionPharmacological StudyPharmacokinetic ProfileMedicineEslicarbazepine Acetate	2005	50

Page 1